Quidel Corp. (QDEL) was a big mover last session, as its shares rose almost 8% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 25% in the past one-month time frame.
In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Quidel currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some better-ranked medical stocks include Lannett Company, Inc. (LCI), Jazz Pharmaceuticals Plc (JAZZ) and NuVasive, Inc. (NUVA). All three companies carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
QUIDEL CP (QDEL): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
NUVASIVE INC (NUVA): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading